OUR PRODUCTS

MOBILE APPS

GENERAL INFO

NUVL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Nuvalent (NUVL) Earnings Date & Reports

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NUVL is expected to report earnings to fall 9.35% to -125 cents per share on November 06

Q3'25

Est.

$-1.26

Q2'25

Missed

by $0.17

Q1'25

Missed

by $0.05

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.34

The last earnings report on August 07 showed earnings per share of -138 cents, missing the estimate of -122 cents. With 387.99K shares outstanding, the current market capitalization sits at 5.34B.

View a ticker or compare two or three

Compare

NUVL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NUVL
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NUVL showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Broadway

Phone

+1 857 357-7000

Employees

Web

https://www.nuvalent.com